Request Sample

Global Rheumatoid Arthritis Diagnostic Tests Market

Sept. 14, 2019

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid and other tests), monitoring RA treatment efficiency tests (salicylate level count, muscle enzyme tests (CPK, Aldolase) and creatinine test), By End User (Diagnostics laboratories, Ambulatory surgical centers, Hospitals), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR634      
Pages :229 Pages
Format :   PPT Format   PDF Format

The global rheumatoid arthritis diagnostic tests market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Rheumatoid arthritis (RA) is an autoimmune disease which impacts body’s own immune system by attacking its joint tissues, which leads to swelling of joint lining. Such swelling of joint lining results in unbearable pain, stiffness, soreness, burning, and redness. This disorder has no enduring cure and it lasts for long term. The chronic nature of rheumatoid arthritis has played a vital role in lavishing the growth of the global rheumatoid arthritis diagnosis tests market. Owing to advancements in the field of osteopathy and anatomy, the market is expected to grow tremendously. 

Table 1. Global Rheumatoid Arthritis Diagnostic Tests Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Test Type)

serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid and other tests), monitoring RA treatment efficiency tests (salicylate level count, muscle enzyme tests (CPK, Aldolase) and creatinine test)

Market Segmentation (By End User)

Diagnostics laboratories, Ambulatory surgical centers, Hospitals

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

 Beckman Coulter, Inc., Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Euro Diagnostica AB, Qiagen NV, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., WorldCare Clinical, and Thermo Fisher Scientific Inc., among others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The demand within the global market has been surging due to rising requirement for enhanced technologies in the field of diagnostics. For instance, in February, 2019, University of Virginia School of Medicine researchers have studied and discovered an unpredicted contributor to rheumatoid arthritis comes under the Traversing Tubing Technologies, which assists in describing the painful flare-ups linked with the disorder. The invention is mainly pivoting the potential new treatment of the autoimmune disease and can also assist with the use of blood test to diagnose the patient who are at severe danger for developing the situation. Furthermore, the presence of advanced healthcare facilities to treat chronic diseases and increasing occurrence of rheumatoid arthritis amongst the geriatric population plays major role in driving the growth of rheumatoid arthritis diagnostic tests market, globally. For instance, as per the National Center for Biotechnology Information (NCBI), in November 2019, the age-standardized point occurrence and yearly incidence rates of RA were 246.6 and 14.9 in 2017, which expanded by 7.4% and 8.2% from 1990, in US respectively.

However, limited availability of test kits in the market is predicted to restrain the growth of global rheumatoid arthritis diagnostic tests market.

Figure 1. PORTER’S Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

The market for rheumatoid arthritis diagnosis in Europe and North America is inflating with higher rate because of rising overall occurrence rate, adoption of slightly invasive test procedures to detect rheumatoid arthritis. For Instance, in the U.K., July 2019, the researchers of University of  Birmingham’s School of Computer Science, have introduced a non-invasive diagnostic technique to diagnose rheumatoid arthritis within time span of less than 2 minutes and assists the clinicians to adopt more effective and accurate treatments. It unites 3D digital imaging with infrared spectroscopy to develop a 3D image of blood level inside the arms of patients that can be used to create an objective, quantifiable assessment.  Moreover, as per the European League Against Rheumatism, June 2019, it is been calculated that approximately 120 million people are currently surviving with rheumatoid arthritis diseases in Europe and this number is 50 million in the U.S. adults. Hence, there is a massive demand for rheumatoid arthritis diagnosis test kits in these regions, surging the growth of the overall rheumatoid arthritis diagnostic tests market, globally.

Figure 2. Regional Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in the global rheumatoid arthritis diagnostic tests market include: Beckman Coulter, Inc., Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Euro Diagnostica AB, Qiagen NV, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., WorldCare Clinical, and Thermo Fisher Scientific Inc., among others.

The major players in the market are pivoting various strategies such as investment in R&D, new launches and partnerships to retain their market share. For instance, in March 2020, WorldCare Clinical, LLC, an independent CRO which provides imaging in clinical trials collaborated with Navidea Biopharmaceuticals, Inc. to offer imaging service following the FDA approval of Navidea’s RA diagnostic. Moreover, in February 2020, researchers from Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Germany, published that serum markers can be used to diagnose swelling in patients in joint ailments. Such efforts of partnerships and investment in R&D help the key players to expand their product portfolio.

Figure 3. Market Share of Key Players, 2019

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Test Type

  • Serology Tests
  • Erythrocyte Sedimentation Rate (ESR)
  • Rheumatoid Factor (RF)
  • Anti-cyclic Citrullinated Peptide (anti-CCP)
  • Antinuclear Antibody (ANA)
  • Uric acid and Other Tests
  • Monitoring RA Treatment Efficiency Tests
  • Salicylate Level Count
  • Muscle Enzyme Tests (CPK, Aldolase)
  • Creatinine Test

By End User

  • Diagnostics laboratories
  • Ambulatory surgical centers
  • Hospitals

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global rheumatoid arthritis diagnostic tests market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global rheumatoid arthritis diagnostic tests market?
  • What key factors are expected to increase the demand for rheumatoid arthritis diagnostic tests market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global rheumatoid arthritis diagnostic tests market?
  • What is the total market value (US$ Mn) generated in global rheumatoid arthritis diagnostic tests market by test type in 2019 and what are the forecasts by 2025?
  • Which end user is expected to dominate the rheumatoid arthritis diagnostic tests market in the coming years?
  • What was the total revenue generated by the global rheumatoid arthritis diagnostic tests market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global rheumatoid arthritis diagnostic tests market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the rheumatoid arthritis diagnostic tests market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.